NCT06766864View on ClinicalTrials.gov

A Study of Subcutaneous DR-01 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

March 3, 2025

Primary Completion Date

August 27, 2025

Study Completion Date

August 27, 2025

Conditions

Healthy Volunteer

Interventions

DRUG

DR-01

DR-01 is a monoclonal antibody

OTHER

Placebo

Placebo

Trial Locations (1)

1010

Dren Investigational Site, Auckland

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Dren Bio

INDUSTRY

NCT06766864 - A Study of Subcutaneous DR-01 in Healthy Volunteers | Biotech Hunter | Biotech Hunter